Back to search
FDAFDA · Food and drugs·Recall number D-0082-2018

Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-122-06

Published November 22, 2017 · Recall initiated: October 30, 2017

Summary

FDA records drug Class III recall D-0082-2018, published November 22, 2017 and initiated October 30, 2017. Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 744 bottles; Lot: Lot # 17P0430, Exp 05/19. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.

What to do

Voluntary: Firm initiated · Letter

Get an email if MECLIZINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MECLIZINE HYDROCHLORIDE
Manufacturer
Jubilant Cadista Pharmaceuticals, Inc.
Distributor
Nationwide
UPC
0359746121068
Lot
Lot # 17P0430, Exp 05/19
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-122-06 recalled?

Yes. FDA published recall D-0082-2018 on November 22, 2017. Reported hazard: Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MECLIZINE HYDROCHLORIDE. UPC: 0359746121068.